CCCC ▼ -3.5% - C4 Therapeutics, Inc.
$CCCC - C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders
29-OCT-2026 07:00 AM ET
Share this post
More filings for $CCCC
CCCC ▲ +0.7% - C4 Therapeutics, Inc.Sep 25, 2026CCCC ▲ +2.4% - C4 Therapeutics, Inc.Sep 3, 2026CCCC - C4 Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CCCC - C4 Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CCCC - C4 Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CCCC - C4 Therapeutics, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026
View full $CCCC filing history →💬 Comments
Loading comments…
Leave a comment